The CEO of Moderna, Stephane Bancel, recently said the biotech company may have results on its coronavirus vaccine candidate by November, says a report.
A World Health Organization (WHO) official this week warned of the “alarming rates of transmission” of the novel coronavirus in Europe, urging residents there to view the “very serious situation unfolding before us” as a “wake up call.”
Social and mental stimulation both play a critical role in slowing dementia, and doctors have reported increased backsliding in patients who had been stable for years.
While data is limited around birth outcomes and COVID-19, two new federal reports found that at least half of pregnant women infected with the virus were asymptomatic, or showed no symptoms.
An alarming upward trend in stillbirths has prompted a warning from doctors that the coronavirus has made both patients and global health care systems more vulnerable than previously thought — and with far-reaching impact.
Dr. Shashi Gujar, with the department of pathology at Dal, along with colleagues in the United States, Denmark, France, Germany, and India, is studying if the immune response against SARS-CoV-2, the virus that causes COVID-19, could be repurposed to fight cancer using the immune system, according to a news release on the Dalhousie University website.
Dr. Robert Redfield, director for the Centers for Disease Control and Prevention (CDC), said a coronavirus vaccine may be generally available to the American public by the late second quarter to the third quarter of 2021.
Less than 1% of coronavirus-related deaths were among Americans younger than 21, and minorities and those with underlying conditions accounted for the vast majority of lives lost, according to new data.
State and local officials around the U.S. are rolling back social-distancing rules again after an abortive effort over the summer, allowing bars, restaurants and gyms to open.